NP-1, a rabbit α-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2

Sara Sinha, Natalia V. Cheshenko, Robert I. Lehrer, Betsy Herold

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Rabbit neutrophil peptide-1 (NP-1), a prototypic α-defensin, protects cells in vitro from infection by clinical and laboratory isolates of herpes simplex virus type 2 (HSV-2). Incubation of concentrated virus stocks for 1 h with noncytotoxic concentrations of NP-1 reduces subsequent infection by >98%. Pretreating cells with NP-1 for 1 h prior to inoculation with untreated virus also prevents infection. NP-1, a cationic peptide, does not compete with viral envelope glycoproteins for binding to cellular heparan sulfate receptors, but it prevents viral entry. No VP16, a major viral tegument protein, is transported to the cell nucleus in the presence of NP-1. Infectious center assays demonstrate that NP-1 also inhibits cell-to-cell viral spread. Thus, NP-1 prevents virally mediated fusion events, entry, and cell-to-cell spread. This unique mechanism of anti-HSV activity, coupled with established antibacterial and possible anti-human immunodeficiency virus type 1 activities of defensins, render this family of compounds excellent candidates for further development as topical microbicides.

Original languageEnglish (US)
Pages (from-to)494-500
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume47
Issue number2
DOIs
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Defensins
Human Herpesvirus 2
Neutrophils
Peptides
Laboratory Infection
Viruses
Local Anti-Infective Agents
Heparitin Sulfate
Viral Proteins
Infection
Oryctolagus cuniculus NP-1 protein
Cell Nucleus
HIV-1
Glycoproteins

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

NP-1, a rabbit α-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. / Sinha, Sara; Cheshenko, Natalia V.; Lehrer, Robert I.; Herold, Betsy.

In: Antimicrobial Agents and Chemotherapy, Vol. 47, No. 2, 01.02.2003, p. 494-500.

Research output: Contribution to journalArticle

@article{24e777ae169344d99db4af4c4773b28f,
title = "NP-1, a rabbit α-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2",
abstract = "Rabbit neutrophil peptide-1 (NP-1), a prototypic α-defensin, protects cells in vitro from infection by clinical and laboratory isolates of herpes simplex virus type 2 (HSV-2). Incubation of concentrated virus stocks for 1 h with noncytotoxic concentrations of NP-1 reduces subsequent infection by >98{\%}. Pretreating cells with NP-1 for 1 h prior to inoculation with untreated virus also prevents infection. NP-1, a cationic peptide, does not compete with viral envelope glycoproteins for binding to cellular heparan sulfate receptors, but it prevents viral entry. No VP16, a major viral tegument protein, is transported to the cell nucleus in the presence of NP-1. Infectious center assays demonstrate that NP-1 also inhibits cell-to-cell viral spread. Thus, NP-1 prevents virally mediated fusion events, entry, and cell-to-cell spread. This unique mechanism of anti-HSV activity, coupled with established antibacterial and possible anti-human immunodeficiency virus type 1 activities of defensins, render this family of compounds excellent candidates for further development as topical microbicides.",
author = "Sara Sinha and Cheshenko, {Natalia V.} and Lehrer, {Robert I.} and Betsy Herold",
year = "2003",
month = "2",
day = "1",
doi = "10.1128/AAC.47.2.494-500.2003",
language = "English (US)",
volume = "47",
pages = "494--500",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - NP-1, a rabbit α-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2

AU - Sinha, Sara

AU - Cheshenko, Natalia V.

AU - Lehrer, Robert I.

AU - Herold, Betsy

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Rabbit neutrophil peptide-1 (NP-1), a prototypic α-defensin, protects cells in vitro from infection by clinical and laboratory isolates of herpes simplex virus type 2 (HSV-2). Incubation of concentrated virus stocks for 1 h with noncytotoxic concentrations of NP-1 reduces subsequent infection by >98%. Pretreating cells with NP-1 for 1 h prior to inoculation with untreated virus also prevents infection. NP-1, a cationic peptide, does not compete with viral envelope glycoproteins for binding to cellular heparan sulfate receptors, but it prevents viral entry. No VP16, a major viral tegument protein, is transported to the cell nucleus in the presence of NP-1. Infectious center assays demonstrate that NP-1 also inhibits cell-to-cell viral spread. Thus, NP-1 prevents virally mediated fusion events, entry, and cell-to-cell spread. This unique mechanism of anti-HSV activity, coupled with established antibacterial and possible anti-human immunodeficiency virus type 1 activities of defensins, render this family of compounds excellent candidates for further development as topical microbicides.

AB - Rabbit neutrophil peptide-1 (NP-1), a prototypic α-defensin, protects cells in vitro from infection by clinical and laboratory isolates of herpes simplex virus type 2 (HSV-2). Incubation of concentrated virus stocks for 1 h with noncytotoxic concentrations of NP-1 reduces subsequent infection by >98%. Pretreating cells with NP-1 for 1 h prior to inoculation with untreated virus also prevents infection. NP-1, a cationic peptide, does not compete with viral envelope glycoproteins for binding to cellular heparan sulfate receptors, but it prevents viral entry. No VP16, a major viral tegument protein, is transported to the cell nucleus in the presence of NP-1. Infectious center assays demonstrate that NP-1 also inhibits cell-to-cell viral spread. Thus, NP-1 prevents virally mediated fusion events, entry, and cell-to-cell spread. This unique mechanism of anti-HSV activity, coupled with established antibacterial and possible anti-human immunodeficiency virus type 1 activities of defensins, render this family of compounds excellent candidates for further development as topical microbicides.

UR - http://www.scopus.com/inward/record.url?scp=0037308626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037308626&partnerID=8YFLogxK

U2 - 10.1128/AAC.47.2.494-500.2003

DO - 10.1128/AAC.47.2.494-500.2003

M3 - Article

C2 - 12543649

AN - SCOPUS:0037308626

VL - 47

SP - 494

EP - 500

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -